Financial Results attached
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sunshield Chemicals' Board approved unaudited financial results for Q3 FY26 (quarter ended Dec 31, 2025) and 9M FY26, with the statutory auditor issuing an unmodified (clean) limited review report. Revenue from operations for 9M FY26 stood at Rs 33,124 lakhs, up about 30% from Rs 25,548 lakhs in 9M FY25, while Q3 revenue grew to Rs 9,496 lakhs from Rs 8,461 lakhs. Profit after tax jumped sharply to Rs 1,894 lakhs for 9M FY26 (Rs 489 lakhs for the quarter) versus Rs 883 lakhs (Rs 163 lakhs) a year ago, supported by margin expansion and lower finance costs. The company recently completed a Rights Issue of Rs 12,990.40 lakhs (14.41 lakh shares at Rs 901 each), with proceeds fully utilised for debt repayment and general corporate purposes, which has visibly reduced interest expenses. Operating margins improved meaningfully as finance costs fell from Rs 242 lakhs in Q3 FY25 to Rs 74 lakhs in Q3 FY26.
Strong topline growth, more than doubled profits, and deleveraging via the Rights Issue are positive signals for shareholders, likely supporting the stock. Investors should note that the higher share count post-Rights Issue partly tempers per-share earnings comparisons.